FIGURE 7.

LINC00525 promotes LUAD tumorigenesis in vivo. A‐C. Xenograft tumor models showing that LINC00525 knockdown inhibited, whereas LINC00525 overexpression promoted LUADgrowth in vivo. D. Hematoxylin and Eosin and IHC stanning of xenograft tumor tissues showing that tumors derived from sh‐LINC00525 group with fewer Ki67 and cyclin D1‐postive cells, but more P21‐positvie cells. E. Hematoxylin and Eosin and IHC stanning of xenograft tumor tissues showing that tumors derived from LINC00525 group with more Ki67 and cyclin D1‐postive cells but fewer P21‐positvie cells. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars, SEM. Abbreviations: ORF, open reading frame; 3'UTR, 3'‐untranslated region; IHC, Immunohistochemical